BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 30696488)

  • 1. Analyses of the factors influencing the accuracy of three-dimensional ultrasound in comparison with cone-beam CT in image-guided radiotherapy for prostate cancer with or without pelvic lymph node irradiation.
    Zhou S; Luo L; Li J; Lin M; Chen L; Shao J; Lu S; Ma Y; Zhang Y; Chen W; Liu M; Liu S; He L
    Radiat Oncol; 2019 Jan; 14(1):22. PubMed ID: 30696488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between volume changes and spatial dose metrics for the urinary bladder during local versus pelvic irradiation for prostate cancer.
    Casares-Magaz O; Moiseenko V; Hopper A; Pettersson NJ; Thor M; Knopp R; Deasy JO; Muren LP; Einck J
    Acta Oncol; 2017 Jun; 56(6):884-890. PubMed ID: 28401808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of daily soft-tissue image guidance to prostate on pelvic lymph node (PLN) irradiation for prostate patients receiving SBRT.
    Tyagi N; Hipp E; Cloutier M; Charas T; Fontenla S; Mechalakos J; Hunt M; Zelefsky M
    J Appl Clin Med Phys; 2019 Jul; 20(7):121-127. PubMed ID: 31206236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative assessment of prostate positioning guided by three-dimensional ultrasound and cone beam CT.
    Li M; Ballhausen H; Hegemann NS; Ganswindt U; Manapov F; Tritschler S; Roosen A; Gratzke C; Reiner M; Belka C
    Radiat Oncol; 2015 Apr; 10():82. PubMed ID: 25890013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTV margin analysis for prostate patients treated with initial pelvic nodal IMRT and prostate proton boost.
    Su Z; Li Z; Henderson R; Hoppe B; Nichols RC; Bryant C; Mendenhall W; Mendenhall N
    Phys Med Biol; 2019 Feb; 64(4):04NT04. PubMed ID: 30630135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric evaluation of three adaptive strategies for prostate cancer treatment including pelvic lymph nodes irradiation.
    Cantin A; Gingras L; Lachance B; Foster W; Goudreault J; Archambault L
    Med Phys; 2015 Dec; 42(12):7011-21. PubMed ID: 26632056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential failure risk of the cone-beam computed tomography-based planning target volume margin definition for prostate image-guided radiotherapy based on a prospective single-institutional hybrid analysis.
    Hirose K; Sato M; Hatayama Y; Kawaguchi H; Komai F; Sohma M; Obara H; Suzuki M; Tanaka M; Fujioka I; Ichise K; Takai Y; Aoki M
    Radiat Oncol; 2018 Jun; 13(1):106. PubMed ID: 29880006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A feature alignment score for online cone-beam CT-based image-guided radiotherapy for prostate cancer.
    Hargrave C; Deegan T; Poulsen M; Bednarz T; Harden F; Mengersen K
    Med Phys; 2018 Jul; 45(7):2898-2911. PubMed ID: 29772077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of the three degrees-of-freedom fiducial marker-based setup compared to soft tissue-based setup in hypofractionated intensity-modulated radiotherapy for prostate cancer.
    Tanabe S; Utsunomiya S; Abe E; Sato H; Ohta A; Sakai H; Yamada T; Kaidu M; Aoyama H
    J Appl Clin Med Phys; 2019 Jun; 20(6):53-59. PubMed ID: 31054217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of prostate positioning guided by three-dimensional transperineal ultrasound and cone beam CT.
    Li M; Ballhausen H; Hegemann NS; Reiner M; Tritschler S; Gratzke C; Manapov F; Corradini S; Ganswindt U; Belka C
    Strahlenther Onkol; 2017 Mar; 193(3):221-228. PubMed ID: 27928626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superiority of a soft tissue-based setup using cone-beam computed tomography over a bony structure-based setup in intensity-modulated radiotherapy for prostate cancer.
    Sato H; Abe E; Utsunomiya S; Kaidu M; Yamana N; Tanaka K; Ohta A; Obinata M; Liu J; Kawaguchi G; Maruyama K; Ayukawa F; Aoyama H
    J Appl Clin Med Phys; 2015 Sep; 16(5):239–245. PubMed ID: 26699304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity-modulated radiotherapy (IMRT) to prostate and pelvic nodes-is pelvic lymph node coverage adequate with fiducial-based image-guided radiotherapy?
    Eminowicz G; Dean C; Shoffren O; Macdougall N; Wells P; Muirhead R
    Br J Radiol; 2014 May; 87(1037):20130696. PubMed ID: 24646126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of margins in pelvic lymph nodes and prostate radiotherapy and the impact of bladder and rectum on prostate position.
    Marnouche EA; Hadadi K; Abdelhak M; Benlemlih M; Hommadi M; Zaghba N; Andaloussi Saghir K; Elmarjany M; Sifat H; Mansouri H
    Cancer Radiother; 2021 Apr; 25(2):161-168. PubMed ID: 33454191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Image-guided radiotherapy (IGRT) for prostate cancer comparing kV imaging of fiducial markers with cone beam computed tomography (CBCT).
    Barney BM; Lee RJ; Handrahan D; Welsh KT; Cook JT; Sause WT
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):301-5. PubMed ID: 20864274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of MRI-based reference images for image-guided radiotherapy of the pelvis with either cone-beam computed tomography or planar localization images.
    Korhonen J; Kapanen M; Sonke JJ; Wee L; Salli E; Keyriläinen J; Seppälä T; Tenhunen M
    Acta Oncol; 2015 Jun; 54(6):889-95. PubMed ID: 25233439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance lymphography-guided selective high-dose lymph node irradiation in prostate cancer.
    Meijer HJ; Debats OA; Kunze-Busch M; van Kollenburg P; Leer JW; Witjes JA; Kaanders JH; Barentsz JO; van Lin EN
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):175-83. PubMed ID: 21075555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic lymph node displacement in high-risk prostate cancer patients treated with image guided intensity modulated radiation therapy with 2 independent target volumes.
    Lecavalier-Barsoum M; Souhami L; Cury F; Duclos M; Ruo R; Faria S
    Pract Radiat Oncol; 2015; 5(6):406-10. PubMed ID: 26127006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion on the planning target volume for prostate cancer patients.
    Böckelmann F; Putz F; Kallis K; Lettmaier S; Fietkau R; Bert C
    Strahlenther Onkol; 2020 Jul; 196(7):647-656. PubMed ID: 32157345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geometric discrepancy of image-guided radiation therapy in patients with prostate cancer without implanted fiducial markers using a commercial pseudo-CT generation method.
    Kan H; Eguchi Y; Tsuchiya T; Kondo T; Kitagawa Y; Mekata Y; Fukuma H; Yoshida R; Kasai H; Kunitomo H; Hirose Y; Shibamoto Y
    Phys Med Biol; 2019 Mar; 64(6):06NT01. PubMed ID: 30695772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic nodal dosing with registration to the prostate: implications for high-risk prostate cancer patients receiving stereotactic body radiation therapy.
    Kishan AU; Lamb JM; Jani SS; Kang JJ; Steinberg ML; King CR
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):832-9. PubMed ID: 25752398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.